Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results.
Pereyra-Rodríguez JJ, Herranz P, Ruiz-Villaverde R, Elosua-González M, Galán-Gutiérrez M, Figueras-Nart I, Miquel J, de la Cueva P, Serra-Baldrich E, Munera-Campos M, Melé-Ninot G, Expósito-Serrano V, Perez B, Serrano A, Ortiz de Frutos JF, Armario-Hita JC. Pereyra-Rodríguez JJ, et al. Clin Exp Dermatol. 2023 Aug 25;48(9):991-997. doi: 10.1093/ced/llad153. Clin Exp Dermatol. 2023. PMID: 37098171
Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria.
Curto-Barredo L, Spertino J, Figueras-Nart I, Expósito-Serrano V, Guilabert A, Melé-Ninot G, Cubiró X, Bonfill-Ortí M, Garcias-Ladaria J, Villar M, García-Navarro X, Bielsa-Marsol I, Vilavella M, Aparicio G, Baliu-Piqué C, Álvarez A, Lamas-Domenech N, Duran-Jordà X, Serra-Baldrich E, Giménez-Arnau A. Curto-Barredo L, et al. Br J Dermatol. 2018 Jul;179(1):210-212. doi: 10.1111/bjd.16379. Epub 2018 Apr 25. Br J Dermatol. 2018. PMID: 29368377 No abstract available.
Algorithm for Treatment of Chronic Spontaneous Urticaria with Omalizumab.
Spertino J, Curto Barredo L, Rozas Muñoz E, Figueras Nart I, Gimenez Arnau A, Serra Baldrich E, Bonfill-Ortí M, Expósito-Serrano V, Guilabert A, Melé Ninot G, Villar Buil M, Garcias Ladaria J, García Navarro X, Vilavella M, Bielsa Marsol I, Aparicio Ortiz G, Baliu Piqué C, Álvarez Abella A, Lamas Domenech N, Mascaró JM, Gómez S, Torné Gutiérrez JI, Vicente Villa A, Gimenez Arnau A. Spertino J, et al. Actas Dermosifiliogr (Engl Ed). 2018 Nov;109(9):771-776. doi: 10.1016/j.ad.2018.07.005. Epub 2018 Aug 11. Actas Dermosifiliogr (Engl Ed). 2018. PMID: 30107875 English, Spanish.
Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series.
Armario-Hita JC, Pereyra-Rodriguez J, Silvestre JF, Ruiz-Villaverde R, Valero A, Izu-Belloso R, Jáuregui-Presa I, Curto-Barredo L, Figueras-Nart I, Herranz-Pinto P, Herraez-Herrera L, Ortiz-de-Frutos FJ, Martinez-Pilar L, Sastre J, Serra-Baldrich E. Armario-Hita JC, et al. Br J Dermatol. 2019 Nov;181(5):1072-1074. doi: 10.1111/bjd.18041. Epub 2019 Jul 25. Br J Dermatol. 2019. PMID: 31021399 No abstract available.
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.
Galván Casas C, Català A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A, Navarro Fernández I, Ruiz-Villaverde R, Falkenhain-López D, Llamas Velasco M, García-Gavín J, Baniandrés O, González-Cruz C, Morillas-Lahuerta V, Cubiró X, Figueras Nart I, Selda-Enriquez G, Romaní J, Fustà-Novell X, Melian-Olivera A, Roncero Riesco M, Burgos-Blasco P, Sola Ortigosa J, Feito Rodriguez M, García-Doval I. Galván Casas C, et al. Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10. Br J Dermatol. 2020. PMID: 32348545 Free PMC article.
Patch Testing During the COVID-19 Pandemic: Recommendations of the AEDV's Spanish Contact Dermatitis and Skin Allergy Research Group (GEIDAC).
Carrascosa JM, Pastor-Nieto MA, Ruiz-González I, Silvestre JF, Borrego L, Gatica-Ortega ME, Giménez-Arnau AM; en representación del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC); Miembros del Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea (GEIDAC). Carrascosa JM, et al. Actas Dermosifiliogr (Engl Ed). 2020 Oct;111(8):650-654. doi: 10.1016/j.ad.2020.06.003. Epub 2020 Jul 2. Actas Dermosifiliogr (Engl Ed). 2020. PMID: 32622869 Free PMC article. English, Spanish.
Omalizumab for the treatment of chronic inducible urticaria in 80 patients.
Exposito-Serrano V, Curto-Barredo L, Aguilera Peiro P, Gómez Armayones S, Serra-Baldrich E, Spertino J, Bonfill Ortí M, Figueras Nart I, Melé-Ninot G, Baliu-Piqué C, Sala Cunill A, Labrador-Horrillo M, Guilabert Vidal A, Fernández Chico N, Giménez-Arnau AM. Exposito-Serrano V, et al. Br J Dermatol. 2021 Jan;184(1):167-168. doi: 10.1111/bjd.19425. Epub 2020 Sep 2. Br J Dermatol. 2021. PMID: 32730636 No abstract available.
Definition of Recurrent Chronic Spontaneous Urticaria.
Melé-Ninot G, Serra-Baldrich E, Curto-Barredo L, Figueras-Nart I, Spertino J, Expósito-Serrano V, García-Navarro X, Guilabert A, Bielsa-Marsol I, Giménez-Arnau AM. Melé-Ninot G, et al. Acta Derm Venereol. 2020 Sep 23;100(16):adv00267. doi: 10.2340/00015555-3633. Acta Derm Venereol. 2020. PMID: 32926176 Free PMC article. No abstract available.
Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results.
Pereyra-Rodriguez JJ, Herranz P, Figueras-Nart I, Perez B, Elosua M, Munera-Campos C, Melgosa-Ramos J, Zaragoza V, Silvestre JF, Campos-Domínguez M, Guilabert A, Miquel J, Alcantara-Luna S, Serra-Baldrich E, Armario-Hita JC. Pereyra-Rodriguez JJ, et al. J Investig Allergol Clin Immunol. 2023 Jun 15;33(3):211-213. doi: 10.18176/jiaci.0831. Epub 2022 Jun 7. J Investig Allergol Clin Immunol. 2023. PMID: 35671128 Free article. No abstract available.
32 results